MediciNova, Inc.
MNOV
$1.79
$0.042.29%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 583.80% | -- | -- | -- | -86.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 583.80% | -- | -- | -- | -86.54% |
| Cost of Revenue | 392.78% | -- | -- | -- | -- |
| Gross Profit | 1,798.91% | -- | -- | -- | -98.17% |
| SG&A Expenses | 22.70% | 16.35% | 12.38% | 16.62% | 11.71% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.96% | 6.05% | 8.03% | 13.78% | 24.19% |
| Operating Income | 10.92% | -1.37% | -4.79% | -11.62% | -35.47% |
| Income Before Tax | 8.97% | -5.03% | -8.58% | -16.65% | -44.66% |
| Income Tax Expenses | 9.09% | 9.09% | 9.09% | 83.33% | 83.33% |
| Earnings from Continuing Operations | 8.97% | -5.03% | -8.58% | -16.67% | -44.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.97% | -5.03% | -8.58% | -16.67% | -44.67% |
| EBIT | 10.92% | -1.37% | -4.79% | -11.62% | -35.47% |
| EBITDA | 10.92% | -1.39% | -4.81% | -11.65% | -35.56% |
| EPS Basic | 9.10% | -4.97% | -8.43% | -16.52% | -44.56% |
| Normalized Basic EPS | 9.05% | -5.00% | -8.53% | -16.63% | -44.52% |
| EPS Diluted | 9.10% | -4.97% | -6.63% | -14.45% | -41.34% |
| Normalized Diluted EPS | 9.05% | -5.00% | -8.53% | -16.63% | -44.52% |
| Average Basic Shares Outstanding | 0.12% | 0.04% | 0.12% | 0.09% | 0.09% |
| Average Diluted Shares Outstanding | 0.12% | 0.04% | 0.12% | 0.09% | 0.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |